Top Markets
Coin of the day
Thalia Therapeutics Plc Thalia Therapeutics Plc

Thalia Therapeutics Plc

THAT
Rang in Aktien #40821
Thalia Therapeutics Plc, a specialized pharmaceutical company established in... Thalia Therapeutics Plc, a specialized pharmaceutical company established in 1979 and headquartered in Chellaston, UK, focuses on developing advanced nanoparticle silica delivery systems. These innovative systems are designed to enhance the cellular uptake and effectiveness of various cancer treatments and vaccines. The company's product portfolio includes Nuvec, a unique silica nanoparticle delivery platform distinguished by its irregular surface structure that effectively encapsulates and safeguards genetic material such as siRNA, RNA, and DNA. Additionally, it offers Liptide, a specialized platform engineered for the targeted delivery of a proprietary siRNA sequence to silence fibrotic genes. Thalia Therapeutics is also advancing N4 101, an orally administered inflammation inhibitor currently undergoing pre-clinical evaluation for the treatment of inflammatory bowel disease, alongside ECP105, which is being developed to prevent ocular scarring. The firm, previously known as N4 Pharma Plc, officially rebranded to Thalia Therapeutics Plc in March 2026.
Aktienkurs
$0.00918474
Marktkapitalisierung
$76.44K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
38.04%
Land
GB
Handel Thalia Therapeutics Plc (THAT)

Kategorie

Kursverlauf für Thalia Therapeutics Plc (THAT)
Höchster Schlusskurs: $0.01 am 2026-08-01

Niedrigster Schlusskurs: $19.72 am 1988-07-01
Kursverlauf der Aktie von Thalia Therapeutics Plc von 1988 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -23.91%
2025 0.53%
2024 -32.47%
2023 -55.32%
2022 -70.97%
2021 -27.88%
2020 193.98%
2019 -67.20%
2018 -9.37%
2017 107.27%
2016 67.55%
2015 -88.28%
2014 -41.17%
2013 -1.53%
2012 -7.10%
2011 -37.06%
2010 -7.98%
2009 10.11%
2008 30.93%
2007 -5.43%
2006 -34.35%
2005 -21.21%
2004 8.56%
2003 109.95%
2002 -51.06%
2001 -60.57%
2000 -52.72%
1999 184.06%
1998 -72.12%
1997 -25.89%
1996 -56.96%
1995 42.16%
1994 10.47%
1993 31.78%
1992 64.83%
1991 -9.46%
1990 -47.16%
1989 -28.88%
1988 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$524.78 32.55%
US
$872.51 34.94%
NL
$746.26 9.13%
CH
$1.08K -6.68%
KR
$260.72 17.02%
BE